Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Generics
Filter     Order     Display # 
Date Item Title
07 Feb 2006 Mylan Announces FDA Approval for Cyclobenzaprine Hydrochloride Tablets USP, 5 mg
03 Feb 2006 Perrigo Company Receives FDA Approval To Market Nicotine Lozenges
01 Feb 2006 Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval For Generic Coreg(R) Tablets
30 Jan 2006 Watson Pharmaceuticals Receives FDA Approval for Testosterone Gel Product
30 Jan 2006 Teva Announces Approval of Desmopressin Acetate Tablets
27 Jan 2006 Sandoz Welcomes CHMP Positive Opinion on Omnitrope
27 Jan 2006 Mylan Announces Final FDA Approval for Alprazolam Extended-release Tablets
27 Jan 2006 Taro Receives Tentative Approval for Augmented Betamethasone Dipropionate Lotion ANDA
27 Jan 2006 Taro Receives Tentative Approval for Augmented Betamethasone Dipropionate Lotion ANDA
23 Jan 2006 Andrx Announces Commercialization Agreement with InvaGen
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
Results 401 - 410 of 410

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Toll-Like Receptor (TLR) Agonists & Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics